A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Linagliptin Impurity 108 - Request Quote

Picture of Linagliptin Impurity 108

Linagliptin Impurity 108

SZ CAT No:SZ-L024166
CAS No
NA
Mol.F.
C16H14N6O2
Mol.Wt.
322.3
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Linagliptin Impurity 108 is chemically 3-Methyl-1-((4-methylquinazolin-2-yl)methyl)-3,7-dihydro-1H-purine-2,6-dione. Linagliptin Impurity 108 is supplied with detailed characterization data compliant with regulatory guideline. Linagliptin Impurity 108 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Linagliptin.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

buy high quality Linagliptin Impurity 108

Purchase Linagliptin Impurity 108

Linagliptin Impurity 108 suppliers

Linagliptin Impurity 108 manufacturers

Linagliptin Impurity 108 price

Order Linagliptin Impurity 108

Enquire Linagliptin Impurity 108

Linagliptin Impurity 108 cost

Linagliptin Impurity 108 Supplier

Linagliptin Impurity 108 Distributor

Linagliptin Impurity 108 for Method Validation

Linagliptin Reference Standard

Linagliptin Impurity 108 for ANDA Filing

Linagliptin Impurity 108 for Forced Degradation Studies

Linagliptin Impurity 108 Identification Standards

Linagliptin Impurity 108 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,